Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Shares Outstanding 2006-2019 | GILD

Gilead Sciences shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Gilead Sciences shares outstanding for the quarter ending September 30, 2019 were 1.267B, a 3.06% decline year-over-year.
  • Gilead Sciences 2018 shares outstanding were 1.308B, a 0.83% decline from 2017.
  • Gilead Sciences 2017 shares outstanding were 1.319B, a 2.87% decline from 2016.
  • Gilead Sciences 2016 shares outstanding were 1.358B, a 10.72% decline from 2015.
  
Gilead Sciences Annual Shares Outstanding
(Millions of Shares)
2018 1,308
2017 1,319
2016 1,358
2015 1,521
2014 1,647
2013 1,695
2012 1,583
2011 1,580
2010 1,747
2009 1,868
2008 1,918
2007 1,929
2006 1,836
2005 1,897
Gilead Sciences Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 1,267
Q2 2019 1,277
Q1 2019 1,283
Q4 2018 1,308
Q3 2018 1,307
Q2 2018 1,308
Q1 2018 1,320
Q4 2017 1,319
Q3 2017 1,319
Q2 2017 1,317
Q1 2017 1,320
Q4 2016 1,358
Q3 2016 1,339
Q2 2016 1,355
Q1 2016 1,412
Q4 2015 1,521
Q3 2015 1,503
Q2 2015 1,540
Q1 2015 1,569
Q4 2014 1,647
Q3 2014 1,637
Q2 2014 1,664
Q1 2014 1,680
Q4 2013 1,695
Q3 2013 1,692
Q2 2013 1,695
Q1 2013 1,665
Q4 2012 1,583
Q3 2012 1,585
Q2 2012 1,561
Q1 2012 1,555
Q4 2011 1,580
Q3 2011 1,563
Q2 2011 1,602
Q1 2011 1,624
Q4 2010 1,747
Q3 2010 1,694
Q2 2010 1,798
Q1 2010 1,857
Q4 2009 1,868
Q3 2009 1,865
Q2 2009 1,869
Q1 2009 1,885
Q4 2008 1,918
Q3 2008 1,921
Q2 2008 1,931
Q1 2008 1,933
Q4 2007 1,929
Q3 2007 1,918
Q2 2007 1,936
Q1 2007 1,925
Q4 2006 1,836
Q3 2006 1,830
Q2 2006 1,905
Q1 2006 1,927
Q4 2005 1,897
Q3 2005 1,904
Q2 2005 1,890
Q1 2005 1,870
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $81.779B $22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.136B 15.11
CSL (CSLLY) Australia $84.078B 0.00
Celgene (CELG) United States $77.983B 11.14
Biogen (BIIB) United States $53.075B 9.11
Vertex Pharmaceuticals (VRTX) United States $51.919B 52.99
Illumina (ILMN) United States $43.365B 47.58
Regeneron Pharmaceuticals (REGN) United States $37.813B 16.55
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.123B 11.91
Seattle Genetics (SGEN) United States $18.561B 0.00
Incyte (INCY) United States $18.279B 42.43
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.254B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.531B 0.00
Genmab (GNMSF) Denmark $13.346B 74.86
Exact Sciences (EXAS) United States $10.455B 0.00
Galapagos (GLPG) Belgium $10.396B 26.78
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Alnylam Pharmaceuticals (ALNY) United States $10.307B 0.00
BeiGene (BGNE) Cayman Islands $9.103B 0.00
Bio-Techne Corp (TECH) United States $7.739B 51.80
QIAGEN (QGEN) Netherlands $7.300B 23.80
Sarepta Therapeutics (SRPT) United States $7.065B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.968B 0.00
Guardant Health (GH) United States $6.784B 0.00
Reata Pharmaceuticals (RETA) United States $6.433B 0.00
Amarin (AMRN) Ireland $6.040B 0.00
Moderna (MRNA) United States $5.799B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.621B 14.29
ARGENX SE-ADR (ARGX) Netherlands $4.843B 0.00
Ascendis Pharma (ASND) Denmark $4.773B 0.00
Exelixis (EXEL) United States $4.725B 13.29
China Biologic Products (CBPO) China $4.545B 28.37
Medicines (MDCO) United States $4.414B 0.00
Spark Therapeutics (ONCE) United States $4.287B 0.00
Repligen (RGEN) United States $4.281B 77.58
Mirati Therapeutics (MRTX) United States $4.069B 0.00
Bluebird Bio (BLUE) United States $4.037B 0.00
Adaptive Biotechnologies (ADPT) United States $3.520B 0.00
Blueprint Medicines (BPMC) United States $3.492B 0.00
MorphoSys AG (MOR) Germany $3.378B 0.00
Immunomedics (IMMU) United States $3.326B 0.00
Alkermes (ALKS) Ireland $3.130B 0.00
Genmab (GMAB) Denmark $2.853B 5.88
CRISPR Therapeutics AG (CRSP) Switzerland $2.810B 0.00
Emergent Biosolutions (EBS) United States $2.775B 27.56
Intercept Pharmaceuticals (ICPT) United States $2.683B 0.00
MyoKardia (MYOK) United States $2.563B 0.00
Halozyme Therapeutics (HALO) United States $2.429B 0.00
NeoGenomics (NEO) United States $2.378B 127.22
Acceleron Pharma (XLRN) United States $2.366B 0.00
Amicus Therapeutics (FOLD) United States $2.363B 0.00
UniQure (QURE) Netherlands $2.344B 0.00
Arena Pharmaceuticals (ARNA) United States $2.306B 5.40
Zai Lab (ZLAB) China $2.289B 0.00
RA PHARMCTL INC (RARX) United States $2.202B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.166B 0.00
Ligand Pharmaceuticals (LGND) United States $2.070B 36.79
Cambrex (CBM) United States $2.016B 25.44
Akcea Therapeutics (AKCA) United States $1.819B 0.00
Myriad Genetics (MYGN) United States $1.803B 26.64
Insmed (INSM) United States $1.690B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.583B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.467B 0.00
Denali Therapeutics (DNLI) United States $1.426B 0.00
REGENXBIO (RGNX) United States $1.418B 0.00
Zymeworks (ZYME) Canada $1.369B 0.00
Epizyme (EPZM) United States $1.353B 0.00
Coherus BioSciences (CHRS) United States $1.312B 0.00
Innoviva (INVA) United States $1.238B 3.65
Dicerna Pharmaceuticals (DRNA) United States $1.227B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.153B 0.00
Alector (ALEC) United States $1.148B 0.00
Zealand Pharma (ZLDPF) Denmark $1.143B 0.00
Sangamo Therapeutics (SGMO) United States $1.134B 0.00
Fate Therapeutics (FATE) United States $1.096B 0.00
Zealand Pharma (ZEAL) Denmark $1.044B 11.72
Editas Medicine (EDIT) United States $1.010B 0.00
WAVE Life Sciences (WVE) Singapore $0.926B 0.00
Codexis (CDXS) United States $0.894B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.889B 0.00
Athenex (ATNX) United States $0.880B 0.00
Arvinas (ARVN) United States $0.868B 0.00
Anika Therapeutics (ANIK) United States $0.859B 27.88
Vericel (VCEL) United States $0.856B 319.17
Cara Therapeutics (CARA) United States $0.851B 0.00
Pharming Group (PHGUF) Netherlands $0.799B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.794B 6.67
Principia Biopharma (PRNB) United States $0.768B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.760B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.734B 0.00
Twist Bioscience (TWST) United States $0.716B 0.00
Heska (HSKA) United States $0.700B 178.74
DBV Technologies S.A (DBVT) France $0.699B 0.00
ANI Pharmaceuticals (ANIP) United States $0.694B 11.83
Revance Therapeutics (RVNC) United States $0.682B 0.00
MiMedx (MDXG) United States $0.649B 0.00
Intellia Therapeutics (NTLA) United States $0.634B 0.00
GENFIT S.A (GNFT) France $0.630B 0.00
Mesoblast (MESO) Australia $0.618B 0.00
Adverum Biotechnologies (ADVM) United States $0.591B 0.00
Cellectis S.A (CLLS) France $0.576B 0.00
Retrophin (RTRX) United States $0.549B 0.00
Agenus (AGEN) United States $0.536B 0.00
BioDelivery Sciences (BDSI) United States $0.523B 0.00
Intra-Cellular Therapies (ITCI) United States $0.514B 0.00
UROGEN PHARMA (URGN) United States $0.506B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.491B 0.00
Cytokineticsorporated (CYTK) United States $0.482B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
PHARMA MAR SA (PHMMF) Spain $0.465B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Precision BioSciences (DTIL) United States $0.431B 0.00
Stemline Therapeutics (STML) United States $0.429B 0.00
Kadmon Holdings (KDMN) United States $0.388B 0.00
AC Immune SA (ACIU) Switzerland $0.382B 28.30
Lexicon Pharmaceuticals (LXRX) United States $0.377B 2.61
Merus (MRUS) Netherlands $0.375B 0.00
Dynavax Technologies (DVAX) United States $0.369B 0.00
Prothena (PRTA) Ireland $0.365B 0.00
Bellus Health (BLU) Canada $0.358B 0.00
Arcus Biosciences (RCUS) United States $0.350B 0.00
Cellular Biomedicine (CBMG) United States $0.345B 0.00
Puma Biotechnology (PBYI) United States $0.332B 0.00
PDL BioPharma (PDLI) United States $0.331B 8.29
Pfenex (PFNX) United States $0.331B 0.00
Kindred Biosciences (KIN) United States $0.330B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.314B 0.00
Theratechnologies (THTX) Canada $0.302B 0.00
Geron (GERN) United States $0.296B 0.00
Clovis Oncology (CLVS) United States $0.295B 0.00
Protagonist Therapeutics (PTGX) United States $0.287B 0.00
Avid Bioservices (CDMO) United States $0.286B 0.00
AnaptysBio (ANAB) United States $0.281B 0.00
Compugen (CGEN) Israel $0.279B 0.00
Gritstone Oncology (GRTS) United States $0.268B 0.00
Scholar Rock Holding (SRRK) United States $0.266B 0.00
ADMA Biologics Inc (ADMA) United States $0.260B 0.00
Seres Therapeutics (MCRB) United States $0.255B 0.00
CytomX Therapeutics (CTMX) United States $0.254B 0.00
Biofrontera AG (BFRA) Germany $0.253B 378.53
Sutro Biopharma (STRO) United States $0.250B 0.00
Inovio Pharmaceuticals (INO) United States $0.243B 0.00
Cel-Sci (CVM) United States $0.240B 0.00
MannKind (MNKD) United States $0.235B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.234B 0.00
Albireo Pharma (ALBO) United States $0.234B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Sorrento Therapeutics (SRNE) United States $0.223B 0.00
Kamada (KMDA) Israel $0.215B 8.23
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
XOMA (XOMA) United States $0.212B 0.00
Syros Pharmaceuticals (SYRS) United States $0.212B 0.00
Cue Biopharma (CUE) United States $0.206B 0.00
Athersys (ATHX) United States $0.204B 0.00
Spero Therapeutics (SPRO) United States $0.201B 0.00
OSMOTICA PHARM (OSMT) United States $0.198B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.195B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.189B 0.00
Exicure (XCUR) United States $0.186B 0.00
Palatin Technologies (PTN) United States $0.185B 5.43
Senesco Technologies (ELOX) United States $0.180B 0.00
Arsanis (XFOR) United States $0.177B 0.00
ChromaDex (CDXC) United States $0.170B 0.00
Affimed (AFMD) Germany $0.162B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Nicox SA (NICXF) France $0.150B 0.00
Cerecor (CERC) United States $0.148B 0.00
Prometic Life Sciences (PFSCF) Canada $0.146B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.144B 0.00
Five Prime Therapeutics (FPRX) United States $0.143B 0.00
Ophthotech (ISEE) United States $0.141B 0.00
CorMedix Inc (CRMD) United States $0.140B 0.00
Alcobra (ARCT) United States $0.139B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.138B 0.00
Emmaus Life Sciences (EMMA) United States $0.135B 0.00
Enzo Biochem (ENZ) United States $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.126B 0.00
Abeona Therapeutics (ABEO) United States $0.123B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Menlo Therapeutics (MNLO) United States $0.116B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
SESEN BIO, INC (SESN) United States $0.113B 0.00
NantKwest (NK) United States $0.112B 0.00
PHASEBIO PHARMA (PHAS) United States $0.111B 0.00
Aptinyx (APTX) United States $0.111B 0.00
BioTime (LCTX) United States $0.109B 7.30
Mersana Therapeutics (MRSN) United States $0.107B 0.00
Acorda Therapeutics (ACOR) United States $0.105B 0.00
Fortress Biotech (FBIO) United States $0.104B 0.00
Novavax (NVAX) United States $0.104B 0.00
OvaScience (MLND) United States $0.104B 0.00
VBI Vaccines (VBIV) United States $0.100B 0.00
Strongbridge Biopharma (SBBP) United States $0.093B 2.48
Antibe Therapeutics (ATBPF) Canada $0.091B 0.00
Aduro Biotech (ADRO) United States $0.090B 0.00
Celyad SA (CYAD) Belgium $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.086B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.084B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.082B 0.00
Verastem (VSTM) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
ARAVIVE, INC (ARAV) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Synlogic (SYBX) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.069B 0.00
Checkpoint Therapeutics (CKPT) United States $0.069B 0.00
Liquidia Technologies (LQDA) United States $0.068B 0.00
Trevena (TRVN) United States $0.068B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Selecta Biosciences (SELB) United States $0.063B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.063B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Orgenesis (ORGS) United States $0.056B 3.65
Pluristem Therapeutics (PSTI) Israel $0.053B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Merrimack Pharmaceuticals (MACK) United States $0.052B 0.00
Proteostasis Therapeutics (PTI) United States $0.051B 0.00
Organovo Holdings (ONVO) United States $0.050B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.044B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Unum Therapeutics (UMRX) United States $0.036B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Oncobiologics (OTLK) United States $0.034B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.032B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.95
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.028B 0.00
Entera Bio (ENTX) Israel $0.028B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Celsion (CLSN) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Soligenix (SNGX) United States $0.022B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.021B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Alimera Sciences (ALIM) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.002B 0.00